I came across an article few days ago, while checking the number of canditates for vaccines about COVID-19 where Sinopharm's vaccine development's trial phase caught my eye. The article says that:

In mid-July, Sinopharm launched its phase three trial among 15,000 volunteers—aged 18 to 60, with no serious underlying conditions—in the United Arab Emirates. The company selected the UAE, as it has a diverse population with approximately 200 different nationalities, making it an ideal testing ground.

Now, my question is, why is a diverse population present in UAE or any country with 150+ nationalities ideal for the testing phase of COVID-19? Is it because of the presence of diverse gene pool among the canditates from so many different nationalities? I don't understand why does testing on a population with approx. 200 different nationalities matter. Since, everyone's DNA is different, wouldn't they get the same results if they test it on a large sample space of population whose nationality is the same (for 2-3 generations or more)?


Your Answer

By clicking “Post Your Answer”, you agree to our terms of service, privacy policy and cookie policy

Browse other questions tagged or ask your own question.